Literature DB >> 14609362

Cloning of a cancer cell-producing hepatocyte growth factor, vascular endothelial growth factor, and interleukin-8 from gastric cancer cells.

Mineko Iwai1, Masahiko Matsuda, Yoshiaki Iwai.   

Abstract

A cell colony (IM95m) that produces hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), and interleukin-8 (IL-8) was cloned from gastric cancer cells (IM95 cell line). In culture medium, the highest levels of HGF, VEGF, and IL-8 were about 1.1, 0.9, and 0.17 ng/ml culture medium at 3 d from 10(5) cells. IM95m may be useful in elucidating the role of tumor cells in angiogenesis.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14609362     DOI： 10.1290/1543-706X(2003)039<0288:COACCH>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN： 1071-2690            Impact factor:   2.416


  12 in total

1.  Establishment of an alpha-fetoprotein-producing cell line derived from gastric cancer.

Authors:  M Matsuda; A Watanabe; H Sawada; Y Yamada; H Nakano; M Iwai; Y Iwai
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

2.  Establishment of cultured cell lines derived from a human gastric carcinoma.

Authors:  M Sekiguchi; K Sakakibara; G Fujii
Journal:  Jpn J Exp Med       Date:  1978-02

3.  Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo.

Authors:  X Xin; S Yang; G Ingle; C Zlot; L Rangell; J Kowalski; R Schwall; N Ferrara; M E Gerritsen
Journal:  Am J Pathol       Date:  2001-03       Impact factor: 4.307

4.  Sequential production of CEA and CEA-related antigens in three-dimensional culture of human gastric carcinoma cells.

Authors:  M Iwai; Y Iwai; M Matsuda; A Watanabe; S Imai; H Nakana; T Sugiyama
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

5.  Interleukin 8 and vascular endothelial growth factor -- prognostic factors in human gastric carcinomas?

Authors:  S Kido; Y Kitadai; N Hattori; K Haruma; T Kido; M Ohta; S Tanaka; M Yoshihara; K Sumii; Y Ohmoto; K Chayama
Journal:  Eur J Cancer       Date:  2001-08       Impact factor: 9.162

6.  Correlation between serum levels of interleukin-6 and vascular endothelial growth factor in gastric carcinoma.

Authors:  Shih-Pei Huang; Ming-Shiang Wu; Hsiu-Po Wang; Chang-Shiu Yang; Min-Liang Kuo; Jaw-Town Lin
Journal:  J Gastroenterol Hepatol       Date:  2002-11       Impact factor: 4.029

7.  Cloning of a human hepatocyte growth factor/scatter factor transcription variant from a gastric cancer cell line HSC-39.

Authors:  H Yokozaki; H Tahara; N Oue; E Tahara
Journal:  Int J Oncol       Date:  2000-01       Impact factor: 5.650

8.  Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.

Authors:  Kristan A Keyes; Larry Mann; Karen Cox; Patti Treadway; Philip Iversen; Yun-Fei Chen; Beverly A Teicher
Journal:  Cancer Chemother Pharmacol       Date:  2003-03-18       Impact factor: 3.333

9.  Comparison of seven cell lines derived from human gastric carcinomas.

Authors:  T Motoyama; H Hojo; H Watanabe
Journal:  Acta Pathol Jpn       Date:  1986-01

10.  Human lung cancer cell line producing hepatocyte growth factor/scatter factor.

Authors:  Y Yoshinaga; S Fujita; M Gotoh; T Nakamura; M Kikuchi; S Hirohashi
Journal:  Jpn J Cancer Res       Date:  1992-12
View more
  5 in total

1.  Low-dose interleukin-8 induces the adhesion, migration and invasion of the gastric cancer SGC-7901 cell line.

Authors:  Jun Shi; Pin-Kang Wei
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

2.  Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway-induced resistance to vascular endothelial growth factor receptor inhibitor.

Authors:  Takayuki Nakagawa; Tomohiro Matsushima; Satoshi Kawano; Youya Nakazawa; Yu Kato; Yusuke Adachi; Takanori Abe; Taro Semba; Akira Yokoi; Junji Matsui; Akihiko Tsuruoka; Yasuhiro Funahashi
Journal:  Cancer Sci       Date:  2014-04-28       Impact factor: 6.716

3.  Interleukin-8 does not influence proliferation of the SGC7901 gastric cancer cell line.

Authors:  Jun Shi; Pin-Kang Wei
Journal:  Oncol Lett       Date:  2014-09-12       Impact factor: 2.967

4.  Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification.

Authors:  Jieyi Wang; Liliane Goetsch; Lora Tucker; Qian Zhang; Alexandra Gonzalez; Kedar S Vaidya; Anatol Oleksijew; Erwin Boghaert; Minghao Song; Irina Sokolova; Ekaterina Pestova; Mark Anderson; William N Pappano; Peter Ansell; Anahita Bhathena; Louie Naumovski; Nathalie Corvaia; Edward B Reilly
Journal:  BMC Cancer       Date:  2016-02-16       Impact factor: 4.430

5.  Volitinib, a potent and highly selective c-Met inhibitor, effectively blocks c-Met signaling and growth in c-MET amplified gastric cancer patient-derived tumor xenograft models.

Authors:  Paul R Gavine; Yongxin Ren; Lu Han; Jing Lv; Shiming Fan; Wei Zhang; Wen Xu; Yuan Jie Liu; Tianwei Zhang; Haihua Fu; Yongjuan Yu; Huiying Wang; Shirlian Xu; Feng Zhou; Xinying Su; XiaoLu Yin; Liang Xie; Linfang Wang; Weiguo Qing; Longxian Jiao; Weiguo Su; Q May Wang
Journal:  Mol Oncol       Date:  2014-09-10       Impact factor: 6.603
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.